Product code PSZ— Microbiology

BD VERITOR SYSTEM FOR THE RAPID DETECTION OF FLU A+B

Classification name
Devices Detecting Influenza A, B, And C Virus Antigens
Device class
Class 2
Regulation
21 CFR 866.3328
Advisory panel
Microbiology
Total cleared
72
First cleared
Most recent

FDA classification definition

“An influenza virus antigen detection test system is a device intended for the qualitative detection of influenza viral antigens directly from clinical specimens in patients with signs and symptoms of respiratory infection.”

— U.S. Food and Drug Administration, device classification record for product code PSZ under 21 CFR 866.3328, via openFDA

Market context for product code PSZ

FDA has cleared 72 devices under product code PSZ between 1998 and 2026, filed by 27 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

last 15 years

Top applicants under product code PSZ

Recent clearances under product code PSZ

Data sourced from openFDA. This site is unofficial and independent of the FDA.